Report

Spectral MD - 1Q23 Results

As part of the business combination with Rosecliff Acquisition (Rosecliff) which was announced in April, inaugural quarterly reporting for Spectral MD has commenced, starting with results for 1Q23. Rosecliff has also recently published its full prospectus relating to the transaction which is expected to complete in 3Q23. Under the terms of the transaction, the current shareholders of Spectral MD are expected to own a pro-forma 81.6% of the resultant business, with a conditional pro-forma enterprise value of US$186m, based on a US$10/share price for the combined business. For 1Q23, Spectral MD reported revenue of US$5.1m, a loss per share of US$0.03 and adjusted negative EBITDA of US$3.3m, down YoY, mainly reflecting the expanded work completed by Spectral MD in applications of its technology outside the BARDA funded burn indication.
Underlying
SPECTRAL MD HOLDINGS LTD.

Provider
Capital Access Group
Capital Access Group

Capital Access Group advises companies on effective engagement with investors. Our experienced team offers market-leading access with hard-to-reach investors, including smaller institutions, pension funds and private client fund managers. These under-serviced investors are located not only in London but across the regions of the UK and Europe. We have an unrivalled knowledge of this extensive audience, to whom our published research is distributed, as well as to larger institutions. We offer this service as part of an integrated investor communications strategy to promote a company’s investment story.

Our clients, ranging from AIM to FTSE 100 companies, benefit from our professional, long-term relationships with investors. Not only do we identify and target investors, we contact them directly and relay their views back to clients with analysis, interpretation and advice. This ensures that our clients are in control of their investor engagement. The objective is to improve the reach and engagement with investors, which in turn strengthens the share price.

Analysts
Colin Smith

Other Reports on these Companies
Other Reports from Capital Access Group

ResearchPool Subscriptions

Get the most out of your insights

Get in touch